Most Recent
US biotechnology company ICOS has settled a dispute with Australian-based Arrow Pharma over the patents for erectile dysfunction drug Cialis, less than 12 months after a court upheld the validity of the patents in a separate case.
A proposed Novartis patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step, IP Australia has found, but gave the pharmaceutical giant a chance to amend.
A Chicago jury has ordered an Australian maker of ugg boots to pay US-based footwear company Deckers Outdoor US$450,000 ($643,000) in damages for infringing the company's trade mark.
Bauer Consumer Media has won a five-year legal battle over Evergreen Television's Discover Downunder trade mark, with the Full Federal Court setting aside a prior IP Australia decision and deregistering the mark.
A group of 39 of Australia’s largest universities has managed to avoid paying its full $32.5 million annual fee to Copyright Agency Ltd, while a dispute over the terms of a licence remains unresolved.
Israeli drug maker Teva has won its bid for communications between Germany-based Boehringer and capsule manufacturers to help prove its claim that a patent at the centre of a dispute over the top-selling inhaler Spiriva was invalid for obviousness.
Treasury Wine Estates has won a nearly $352,000 judgment against an Australian company for allegedly violating its trade marks by making and selling copycat Penfolds products in China and Australia.
Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen's patents for its HIV drug Prezista.
Pay TV giant Foxtel has lost an appeal of an IP Australia decision refusing to revoke a trade mark by telco China Unicom after a failure of the trade mark office's online filing system meant its law firm, Allens, missed the deadline for opposing the mark.
Kraft Foods has come up short in its high-stakes legal battle against Bega over the right to use its distinctive peanut butter trade dress in Australia, allowing Bega to maintain its hold on the $60 million per year stake in the peanut butter market which it acquired by purchasing Kraft unit Mondelez's Australian and New Zealand business in 2017.